학술논문
Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis
Document Type
Article
Author
Source
In Annals of Allergy, Asthma & Immunology February 2017 118(2):220-225
Subject
Language
ISSN
1081-1206